Summit Therapeutics (SMMT) Financials: Revenue & Earnings

SMMT price $15.24 -0.09 -0.59%

Ticker
SMMT
Price
$15.24
Change
-0.09 -0.59%
Market cap ?
$12.16B
P/E ?
-12.95
Forward P/E ?
173.11
Dividend yield ?
0.00%
Beta ?
-1.24
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
60
Quality
50
Growth
100

Stocklytics score rationale: value 60, quality 50, growth 100.

Financials

2016201720182019202020212022202320242025
237600014168000570880006118726288751337701583190000

Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered…

Fair value

SMMT fair value Not meaningful. Price $15.24.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful. The model is more than 80% below the live price, which happens for unprofitable or very early companies and is not a price target.

Compare SMMT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-02—-0.28—71.43K
2026-07-23-0.28-0.27—113.89K
2026-04-30-0.24-0.33—54.42K
2026-02-23-0.29-0.10—56.78M
2025-10-20-0.31-0.18—76.50M
2025-08-11-0.76-0.09——
2025-05-01-0.09-0.09——
2025-02-24-0.08-0.08——
2024-10-30-0.08-0.07——
2024-08-06-0.05-0.06——
2024-05-01-0.06-0.06——
2024-02-20-0.042.09—12.31M
2023-11-07-0.03———
2023-08-09-0.02———
2023-05-11-0.06———
2023-03-09-0.07-0.265.00K—
2022-11-09-0.14-0.26220.00K—
2022-08-11-0.17-0.27235.00K—
2022-05-11-0.22-0.28250.00K—
2022-03-17-0.28-0.27251.00K4.45M
2021-11-15-0.20-0.29971.41K1.71M
2021-08-11-0.27-0.1841.21K57.00K
2021-05-17-1.05-0.24139.28K4.08M
2021-03-17-0.90-0.09135.28K4.00M
2020-11-16-1.24-0.01140.28K19.87M
2020-09-29-1.15-0.02137.20K5.13M
2020-06-03-0.10-0.03260.60K5.13M
2019-12-31-0.19—11.73K—
2019-12-17-0.22-0.40120.36K218.83K
2019-10-11-0.20-0.56122.84K—
2019-06-26-0.20-0.164.95M—
2019-03-27-0.35-0.241.04M693.39K
2018-12-11-0.65-0.31857.77K693.39K
2018-09-202.12-0.3749.86M346.83M
2018-06-05-0.52-0.755.33M6.97M
2018-04-13-0.16-0.864.39M3.40M
2017-12-06-0.20-0.583.30M3.40M
2017-08-311.100.354.75M28.47M
2017-06-14-0.50-0.171.73M—
2017-03-29-0.50-0.481.73M1.36M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-08Anand BhaskarBuy100.00K——
2026-06-12Zanganeh MahkamBuy3.81M$13.1249.99M
2026-06-12DUGGAN ROBERT WBuy3.81M$13.1249.99M
2026-06-04DUGGAN ROBERT WBuy100.00K$14.601.46M
2026-06-04Zanganeh MahkamBuy100.00K$14.601.46M
2026-06-04Soni Manmeet SinghBuy25.00K$14.43360.75K
2026-06-04Soni Manmeet SinghBuy25.00K$14.46361.50K
2026-01-08Anand BhaskarBuy30.00K$18.83564.90K
2026-01-02Zanganeh MahkamBuy11.23K$17.52196.78K
2026-01-02DUGGAN ROBERT WBuy11.23K$17.52196.78K
2026-01-02Booth Robert F.Buy35.00K$17.52613.20K
2026-01-02Booth Robert F.Buy7.18K$17.52125.79K
2026-01-02Xia YuBuy35.00K$17.52613.20K
2026-01-02Huber JeffBuy35.00K$17.52613.20K
2026-01-02Huber JeffBuy9.88K$17.52173.19K
2026-01-02Ronaghi MostafaBuy35.00K$17.52613.20K
2026-01-02Clark Kenneth ABuy35.00K$17.52613.20K
2026-01-02Clark Kenneth ABuy17.80K$17.52311.79K
2026-01-02Cesano AlessandraBuy35.00K$17.52613.20K
2026-01-02Cesano AlessandraBuy3.22K$17.5256.40K
2025-10-21Xia YuBuy533.62K$18.7410.00M
2025-10-21Anand BhaskarBuy26.68K$18.74499.98K
2025-10-21Soni Manmeet SinghBuy53.36K$18.74999.99K
2025-10-21DUGGAN ROBERT WBuy13.98M$18.74262.00M
2025-10-21DUGGAN ROBERT WBuy266.81K$18.745.00M
2025-10-21DUGGAN ROBERT WBuy26.68K$18.74499.98K
2025-10-21Zanganeh MahkamBuy13.98M$18.74262.00M
2025-10-21Zanganeh MahkamBuy266.81K$18.745.00M
2025-10-21Zanganeh MahkamBuy26.68K$18.74499.98K
2025-09-18Anand BhaskarBuy50.00K$19.23961.50K
2025-09-11Zanganeh MahkamBuy5.00K$18.0790.35K
2025-09-11DUGGAN ROBERT WBuy5.00K$18.0790.35K
2025-09-10Zanganeh MahkamBuy333.39K$17.685.89M
2025-09-10DUGGAN ROBERT WBuy333.39K$17.685.89M
2025-05-30Zanganeh MahkamBuy74.55K$2.64196.80K
2025-05-30Zanganeh MahkamSell74.55K$2.64196.80K
2025-05-30DUGGAN ROBERT WBuy74.55K$2.64196.80K
2025-05-30DUGGAN ROBERT WSell74.55K$2.64196.80K
2025-04-29Anand BhaskarBuy600.00K$3.852.31M
2025-04-29Anand BhaskarBuy75.00K$17.851.34M
2025-04-29Soni Manmeet SinghBuy11.20M$1.6818.82M
2025-04-29DUGGAN ROBERT WBuy9.59M$1.6816.11M
2025-04-29DUGGAN ROBERT WBuy1.04M$1.061.10M
2025-04-29DUGGAN ROBERT WBuy400.00K$1.29516.00K
2025-04-29Zanganeh MahkamBuy9.59M$1.6816.11M
2025-04-29Zanganeh MahkamBuy1.04M$1.061.10M
2025-04-29Zanganeh MahkamBuy400.00K$1.29516.00K
2025-04-08Zanganeh MahkamBuy3.99M$1.586.30M
2025-04-08Zanganeh MahkamBuy3.99M$1.586.30M
2025-04-08DUGGAN ROBERT WBuy3.99M$1.586.30M
2025-04-08DUGGAN ROBERT WBuy3.99M$1.586.30M
2025-01-12Anand BhaskarBuy75.00K$17.851.34M
2025-01-02DUGGAN ROBERT WBuy10.72K$18.35196.79K
2025-01-02Zanganeh MahkamBuy10.72K$18.35196.79K
2025-01-02Huber JeffBuy35.00K$18.35642.25K
2025-01-02Xia YuBuy35.00K$18.35642.25K
2025-01-02Xia YuBuy5.44K$18.3599.79K
2025-01-02Cesano AlessandraBuy35.00K$18.35642.25K
2025-01-02Cesano AlessandraBuy3.07K$18.3556.39K
2025-01-02Ronaghi MostafaBuy35.00K$18.35642.25K
2025-01-02Clark Kenneth ABuy35.00K$18.35642.25K
2025-01-02Clark Kenneth ABuy16.99K$18.35311.78K
2025-01-02Booth Robert F.Buy35.00K$18.35642.25K
2025-01-02Booth Robert F.Buy6.86K$18.35125.79K
2024-10-11Clark Kenneth ABuy200.00K$19.953.99M
2024-10-03Zanganeh MahkamBuy315.68K$1.58498.78K
2024-10-03Zanganeh MahkamSell315.68K$1.58498.78K
2024-09-11Zanganeh MahkamBuy44.05K$22.70999.98K
2024-09-11DUGGAN ROBERT WBuy3.33M$22.7075.50M
2024-09-11Huber JeffBuy44.05K$22.70999.98K
2024-09-11Soni Manmeet SinghBuy44.05K$22.70999.98K
2024-09-11Anand BhaskarBuy22.03K$22.70499.99K
2024-08-23Soni Manmeet SinghBuy2.80M$1.684.70M
2024-08-23Zanganeh MahkamBuy2.40M$1.684.03M
2024-08-23Zanganeh MahkamBuy260.00K$1.06275.60K
2024-08-23Zanganeh MahkamBuy100.00K$1.29129.00K
2024-06-27Huber JeffBuy17.88K$7.87140.74K
2024-06-27Huber JeffBuy200.00K$7.871.57M
2024-06-27Huber JeffOther0——
2024-04-11Ronaghi MostafaBuy25.32K$4.03102.02K
2024-04-11Ronaghi MostafaBuy200.00K$4.03806.00K
2024-04-11Ronaghi MostafaOther0——
2024-04-02Soni Manmeet SinghBuy1.10M$3.854.24M
2024-04-02Anand BhaskarBuy600.00K$3.852.31M
2024-04-02Anand BhaskarSell0——
2024-03-27Zanganeh MahkamBuy34.32K$3.72127.67K
2024-03-27Zanganeh MahkamBuy26.00K$3.7296.72K
2024-03-27Zanganeh MahkamBuy20.00K$3.7174.20K
2024-03-26Zanganeh MahkamBuy30.00K$3.75112.50K
2024-03-26Dhingra AnkurBuy100.00K$3.75375.00K
2024-01-02Cesano AlessandraBuy21.36K$2.6456.40K
2024-01-02Cesano AlessandraBuy35.00K$2.6492.40K
2024-01-02Booth Robert F.Buy47.65K$2.64125.80K
2024-01-02Booth Robert F.Buy35.00K$2.6492.40K
2024-01-02Clark Kenneth ABuy70.49K$2.64186.10K
2024-01-02Clark Kenneth ABuy35.00K$2.6492.40K
2024-01-02Mahatme UjwalaBuy52.58K$2.64138.80K
2024-01-02Mahatme UjwalaBuy35.00K$2.6492.40K
2024-01-02Xia YuBuy200.00K$2.64528.00K
2024-01-02Xia YuBuy35.00K$2.6492.40K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 269, holders +29 vs prior quarter. Ownership 17.65%.

HolderSharesChangeChange %Value
BAKER BROS. ADVISORS LP32.79M-3.60M-9.91%477.70M
FMR LLC10.04M-809.25K-7.46%146.34M
STATE STREET CORP9.54M2.51M+35.69%138.95M
BLACKROCK, INC.9.53M-124.72K-1.29%138.84M
VANGUARD CAPITAL MANAGEMENT LLC5.73M22.68K+0.40%83.55M
UBS GROUP AG5.23M1.55M+42.21%76.26M
VANGUARD PORTFOLIO MANAGEMENT LLC5.04M-191.06K-3.65%73.46M
GOLDMAN SACHS GROUP INC4.51M4.20M+1352.52%65.76M
PRICE T ROWE ASSOCIATES INC /MD/3.89M-4.38M-52.96%56.73M
POINT72 ASSET MANAGEMENT, L.P.3.70M2.91M+371.55%53.88M
GEODE CAPITAL MANAGEMENT, LLC3.43M111.41K+3.36%49.95M
MILLENNIUM MANAGEMENT LLC2.35M2.22M+1760.32%34.23M
ADAGE CAPITAL PARTNERS GP, L.L.C.1.99M1.99MNew28.99M
BALYASNY ASSET MANAGEMENT L.P.1.90M1.36M+247.28%27.74M
CITADEL ADVISORS LLC1.73M1.61M+1419.12%25.14M
ABERDEEN GROUP PLC1.69M1.03M+154.54%24.68M
SQUAREPOINT OPS LLC1.59M976.86K+159.13%23.18M
MORGAN STANLEY1.45M-200.57K-12.15%21.13M
NORGES BANK1.38M1.38MNew20.14M
LOGOS GLOBAL MANAGEMENT LP1.35M1.35MNew19.67M
OCTAGON CAPITAL ADVISORS LP1.25M1.25MNew18.21M
D. E. SHAW & CO., INC.1.24M-998.67K-44.54%18.12M
KYNAM CAPITAL MANAGEMENT, LP1.20M1.20MNew17.48M
PICTET ASSET MANAGEMENT HOLDING SA1.13M-188.88K-14.27%16.43M
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.11M541.70K+95.45%16.16M

Earnings and financials

Summit Therapeutics Inc. (SMMT) trades at $15.24, with a market cap of $12.16B and a trailing P/E of -12.95. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
237600014168000570880006118726288751337701583190000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Summit Therapeutics (SMMT) Financials: Revenue & Earnings

SMMT$15.24-0.09 -0.59%

$12.16B

Market Cap

-12.95

P/E

173.11

Forward P/E

70

Score

Price History